Kristianne C. Galpin

451 Smyth Road, K1H 8M5
Ottawa, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment.

Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment.

Journal: Frontiers in immunology

Published: June 02, 2025

tp53 R217H and R242H mutant zebrafish exhibit dysfunctional p53 hallmarks and recapitulate Li-Fraumeni syndrome phenotypes.

tp53 R217H and R242H mutant zebrafish exhibit dysfunctional p53 hallmarks and recapitulate Li-Fraumeni syndrome phenotypes.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: June 04, 2024

NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens.

NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens.

Journal: Frontiers in immunology

Published: September 15, 2023

BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy.

BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy.

Journal: Journal of ovarian research

Published: August 18, 2023

FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models.

FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models.

Journal: Scientific reports

Published: July 31, 2023

Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer.

Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer.

Journal: Communications biology

Published: March 03, 2023

The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool For Ovarian Cancer Immunotherapy Research.

The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool For Ovarian Cancer Immunotherapy Research.

Journal: Cancer research communications

Published: October 31, 2022

LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model.

LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model.

Journal: International journal of molecular sciences

Published: June 08, 2020

The Transcriptional Repressor BS69 is a Conserved Target of the E1A Proteins from Several Human Adenovirus Species.

The Transcriptional Repressor BS69 is a Conserved Target of the E1A Proteins from Several Human Adenovirus Species.

Journal: Viruses

Published: October 31, 2018

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics.

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics.

Journal: Cancers

Published: June 29, 2018

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy.

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy.

Journal: Cancers

Published: June 23, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026